Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	small GTPase binding	ABCA1 IQGAP2 MYO9B LRRK2 AP1G1 AFDN FGD5 DIAPH3 TBC1D30 RASGRF1 XPO1 ROCK1 SORL1	2.50e-05	321	202	13	GO:0031267
GeneOntologyMolecularFunction	helicase activity	SETX ATRX MCM6 CHD3 DDX6 HELZ DHX35 DSCC1 DHX30	3.40e-05	158	202	9	GO:0004386
GeneOntologyMolecularFunction	calcium channel activity	TRPC1 TRPC5 RYR2 RYR3 ITPR3 TRPM1 CATSPER1 TRPV4	5.11e-05	129	202	8	GO:0005262
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA1 SETX ATRX ABCA13 MYO9B SRP54 MCM6 CHD3 DDX6 ABCD3 HELZ DHX35 DSCC1 DNHD1 KIF27 MSH3 DHX30 ABCA5	5.53e-05	614	202	18	GO:0140657
GeneOntologyMolecularFunction	GTPase binding	ABCA1 IQGAP2 MYO9B LRRK2 AP1G1 AFDN FGD5 DIAPH3 TBC1D30 RASGRF1 XPO1 ROCK1 SORL1	8.10e-05	360	202	13	GO:0051020
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TRPC1 TRPC5 RYR2 RYR3 ITPR3 TRPM1 CATSPER1 TRPV4	1.54e-04	151	202	8	GO:0015085
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEE POTEF POTEI	1.59e-04	11	202	3	GO:0098973
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	SETX ATRX MCM6 CHD3 DSCC1 MSH3 DHX30	3.14e-04	127	202	7	GO:0008094
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	SETX ATRX GATB MCM6 CHD3 DDX6 HELZ DHX35 DCLRE1A DSCC1 MSH3 NARS2 TRUB2 DHX30 IARS2 TRNT1 TRMT44	3.14e-04	645	202	17	GO:0140640
GeneOntologyMolecularFunction	microtubule binding	LRRK2 CKAP5 DST TUBGCP3 DIAPH3 KIF27 FNTA CEP290 CAPN6 TRPV4 NIN	3.15e-04	308	202	11	GO:0008017
GeneOntologyMolecularFunction	cytoskeletal protein binding	IQGAP2 MYO9B SPTB TRPC5 LRRK2 CKAP5 DST AP1G1 TUBGCP3 AFDN DIAPH3 DMD ESPN SHROOM3 MYOT KIF27 ANK2 FNTA CEP290 CAPN6 AVIL ROCK1 TRPV4 NIN	3.22e-04	1099	202	24	GO:0008092
GeneOntologyMolecularFunction	inositol 1,4,5 trisphosphate binding	TRPC1 TRPC5 ITPR3	3.42e-04	14	202	3	GO:0070679
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	SPTB POTEE TUBGCP3 DMD ANK2 POTEF POTEI	3.61e-04	130	202	7	GO:0005200
GeneOntologyMolecularFunction	actin binding	IQGAP2 MYO9B SPTB TRPC5 LRRK2 DST AFDN DIAPH3 DMD ESPN SHROOM3 MYOT AVIL TRPV4	3.89e-04	479	202	14	GO:0003779
GeneOntologyMolecularFunction	microtubule minus-end binding	TUBGCP3 CEP290 NIN	4.24e-04	15	202	3	GO:0051011
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCA1 ATRX ABCA13 MYO9B SRP54 MCM6 CHD3 DDX6 ABCD3 DHX35 KIF27 DHX30 ABCA5	5.79e-04	441	202	13	GO:0016887
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	6.03e-04	4	202	2	GO:0005219
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RYR2 RYR3 ITPR3	7.44e-04	18	202	3	GO:0015278
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR2 RYR3	1.49e-03	6	202	2	GO:0048763
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA1 ABCA13 ABCD3 ABCA5	1.51e-03	49	202	4	GO:0140359
GeneOntologyCellularComponent	supramolecular fiber	CYP2A7 IQGAP2 MYO9B TRPC1 CKAP5 NCKAP5 RYR2 RYR3 DDX6 POTEE MFAP4 CTPS2 DST TUBGCP3 DIAPH3 DMD ESPN SHROOM3 MYOT KIF27 ANK2 POTEF CAPN6 AVIL TRPV4 CTNNB1 POTEI NIN	9.94e-06	1179	202	28	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	CYP2A7 IQGAP2 MYO9B TRPC1 CKAP5 NCKAP5 RYR2 RYR3 DDX6 POTEE MFAP4 CTPS2 DST TUBGCP3 DIAPH3 DMD ESPN SHROOM3 MYOT KIF27 ANK2 POTEF CAPN6 AVIL TRPV4 CTNNB1 POTEI NIN	1.13e-05	1187	202	28	GO:0099081
GeneOntologyCellularComponent	lamellipodium	IQGAP2 MYO9B FGD5 DMD CASP8 BCAR1 AVIL ROCK1 TRPV4 CTNNB1	8.45e-05	230	202	10	GO:0030027
GeneOntologyCellularComponent	actin cytoskeleton	IQGAP2 MYO9B SPTB SIPA1L3 POTEE DST DIAPH3 ESPN SHLD2 SHROOM3 MYOT POTEF BCAR1 AVIL TRPV4 POTEI	1.59e-04	576	202	16	GO:0015629
GeneOntologyCellularComponent	cell cortex	IQGAP2 MYO9B SPTB EXOC3 STOX1 MELK DST NR3C2 SHROOM3 POTEF TRPV4 CTNNB1	2.76e-04	371	202	12	GO:0005938
GeneOntologyCellularComponent	perinuclear region of cytoplasm	ABCA1 MYO9B EXOC3 RYR3 DDX6 ITPR3 DST AP1G1 DMD ANK2 CNTRL VPS50 CAPN6 VPS54 TFRC USO1 LNPEP RTRAF TLR4 CTNNB1 SORL1	2.92e-04	934	202	21	GO:0048471
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	CYP2A7 IQGAP2 MYO9B CKAP5 NCKAP5 DDX6 POTEE DST TUBGCP3 DIAPH3 DMD ESPN SHROOM3 KIF27 POTEF CAPN6 AVIL TRPV4 POTEI NIN	4.67e-04	899	202	20	GO:0099513
GeneOntologyCellularComponent	intracellular protein-containing complex	GATB PSMD2 JADE1 POTEE NAA25 ANAPC1 TRAPPC6B RMC1 GTF2A1L FNTA POTEF CNTRL GTF2H1 RTRAF UBR3 PSME3 CTNNB1 POTEI SMCR8 SLX4 NIN	4.94e-04	972	202	21	GO:0140535
GeneOntologyCellularComponent	tricellular tight junction	SIPA1L3 MARVELD2	5.50e-04	4	202	2	GO:0061689
GeneOntologyCellularComponent	actin filament	MYO9B POTEE DIAPH3 ESPN POTEF AVIL POTEI	5.54e-04	146	202	7	GO:0005884
GeneOntologyCellularComponent	Z disc	RYR2 RYR3 DST DMD MYOT ANK2 CTNNB1	6.77e-04	151	202	7	GO:0030018
GeneOntologyCellularComponent	axon	SETX TRPC5 INSR LRRK2 EXOC3 POTEE DST SACS AFDN TRPM1 DMD MYOT RASGRF1 POTEF BCAR1 AVIL TRPV4 POTEI NIN	1.07e-03	891	202	19	GO:0030424
GeneOntologyCellularComponent	I band	RYR2 RYR3 DST DMD MYOT ANK2 CTNNB1	1.18e-03	166	202	7	GO:0031674
GeneOntologyCellularComponent	photoreceptor connecting cilium	GNAT1 IFT57 CEP290 WDR19	1.18e-03	48	202	4	GO:0032391
GeneOntologyCellularComponent	costamere	TRPC1 DMD ANK2	1.20e-03	22	202	3	GO:0043034
GeneOntologyCellularComponent	cell leading edge	IQGAP2 MYO9B INSR DST FGD5 DMD CASP8 BCAR1 AVIL TLR4 ROCK1 TRPV4 CTNNB1	1.20e-03	500	202	13	GO:0031252
Domain	P-loop_NTPase	ABCA1 SETX ATRX ABCA13 MYO9B LRRK2 SRP54 MCM6 CHD3 AK3 DDX6 CTPS2 ABCD3 HELZ DHX35 GNAT1 AGAP2 DNHD1 KIF27 MSH3 DIRAS3 DHX30 NPHP3 ABCA5	1.38e-05	848	200	24	IPR027417
Domain	-	TRPC1 TRPC5 LRRK2 ANKRD53 POTEE AGAP2 ESPN ANK2 POTEF ANKRD30A TRPV4 POTEI	1.56e-05	248	200	12	1.25.40.20
Domain	-	ABCA1 SETX ATRX ABCA13 LRRK2 SRP54 MCM6 CHD3 AK3 DDX6 CTPS2 ABCD3 HELZ DHX35 GNAT1 AGAP2 DNHD1 MSH3 DIRAS3 DHX30 NPHP3 ABCA5	1.73e-05	746	200	22	3.40.50.300
Domain	ARM-type_fold	LRRK2 CKAP5 PSMD2 TEX10 RYR3 AP1G1 DIAPH3 COPB1 XPO1 WDFY4 PPP2R5D USO1 ELMO2 CTNNB1	1.82e-05	339	200	14	IPR016024
Domain	Ankyrin_rpt-contain_dom	TRPC1 TRPC5 LRRK2 ANKRD53 POTEE AGAP2 ESPN ANK2 POTEF ANKRD30A TRPV4 POTEI	1.97e-05	254	200	12	IPR020683
Domain	RIH_assoc-dom	RYR2 RYR3 ITPR3	2.36e-05	6	200	3	IPR013662
Domain	Ins145_P3_rec	RYR2 RYR3 ITPR3	2.36e-05	6	200	3	PF08709
Domain	RIH_assoc	RYR2 RYR3 ITPR3	2.36e-05	6	200	3	PF08454
Domain	RIH_dom	RYR2 RYR3 ITPR3	2.36e-05	6	200	3	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3 ITPR3	2.36e-05	6	200	3	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3 ITPR3	2.36e-05	6	200	3	IPR015925
Domain	-	RYR2 RYR3 ITPR3	2.36e-05	6	200	3	1.25.10.30
Domain	RYDR_ITPR	RYR2 RYR3 ITPR3	2.36e-05	6	200	3	PF01365
Domain	Ankyrin_rpt	TRPC1 TRPC5 LRRK2 ANKRD53 POTEE AGAP2 ESPN ANK2 POTEF ANKRD30A TRPV4 POTEI	2.68e-05	262	200	12	IPR002110
Domain	Ion_trans_dom	TRPC1 TRPC5 RYR2 RYR3 ITPR3 TRPM1 CATSPER1 TRPV4	3.14e-05	114	200	8	IPR005821
Domain	Ion_trans	TRPC1 TRPC5 RYR2 RYR3 ITPR3 TRPM1 CATSPER1 TRPV4	3.14e-05	114	200	8	PF00520
Domain	ANK	TRPC1 TRPC5 ANKRD53 POTEE AGAP2 ESPN ANK2 POTEF ANKRD30A TRPV4 POTEI	8.64e-05	251	200	11	SM00248
Domain	ANK_REPEAT	TRPC1 TRPC5 ANKRD53 POTEE AGAP2 ESPN ANK2 POTEF ANKRD30A TRPV4 POTEI	9.27e-05	253	200	11	PS50088
Domain	ANK_REP_REGION	TRPC1 TRPC5 ANKRD53 POTEE AGAP2 ESPN ANK2 POTEF ANKRD30A TRPV4 POTEI	9.60e-05	254	200	11	PS50297
Domain	Vps54_N	VPS50 VPS54	1.14e-04	2	200	2	PF10475
Domain	VPS54_N	VPS50 VPS54	1.14e-04	2	200	2	IPR019515
Domain	MIR	RYR2 RYR3 ITPR3	1.37e-04	10	200	3	PF02815
Domain	MIR_motif	RYR2 RYR3 ITPR3	1.37e-04	10	200	3	IPR016093
Domain	MIR	RYR2 RYR3 ITPR3	1.37e-04	10	200	3	PS50919
Domain	MIR	RYR2 RYR3 ITPR3	1.37e-04	10	200	3	SM00472
Domain	-	LRRK2 CKAP5 PSMD2 TEX10 AP1G1 COPB1 XPO1 WDFY4 ELMO2 CTNNB1	1.45e-04	222	200	10	1.25.10.10
Domain	ARM-like	SETX LRRK2 CKAP5 PSMD2 TEX10 AP1G1 COPB1 XPO1 WDFY4 ELMO2 CTNNB1	1.64e-04	270	200	11	IPR011989
Domain	Ank	TRPC5 ANKRD53 POTEE AGAP2 ESPN ANK2 POTEF ANKRD30A TRPV4 POTEI	1.80e-04	228	200	10	PF00023
Domain	TRP_channel	TRPC1 TRPC5 TRPV4	1.87e-04	11	200	3	IPR004729
Domain	ABC_A	ABCA1 ABCA13 ABCA5	2.48e-04	12	200	3	IPR026082
Domain	Ryanodine_rcpt	RYR2 RYR3	3.40e-04	3	200	2	IPR003032
Domain	PC_rep	PSMD2 ANAPC1	3.40e-04	3	200	2	PF01851
Domain	Ryanrecept_TM4-6	RYR2 RYR3	3.40e-04	3	200	2	IPR009460
Domain	RyR	RYR2 RYR3	3.40e-04	3	200	2	PF02026
Domain	RR_TM4-6	RYR2 RYR3	3.40e-04	3	200	2	PF06459
Domain	Proteasome/cyclosome_rpt	PSMD2 ANAPC1	3.40e-04	3	200	2	IPR002015
Domain	Ryan_recept	RYR2 RYR3	3.40e-04	3	200	2	IPR013333
Domain	Ank_2	TRPC5 ANKRD53 POTEE AGAP2 ESPN ANK2 POTEF ANKRD30A POTEI	5.31e-04	215	200	9	PF12796
Domain	Actin_CS	POTEE POTEF POTEI	6.11e-04	16	200	3	IPR004001
Domain	ACTINS_2	POTEE POTEF POTEI	7.36e-04	17	200	3	PS00432
Domain	Actin/actin-like_CS	POTEE POTEF POTEI	8.77e-04	18	200	3	IPR020902
Domain	ACTINS_ACT_LIKE	POTEE POTEF POTEI	1.03e-03	19	200	3	PS01132
Domain	TRP_2	TRPC1 TRPC5	1.66e-03	6	200	2	PF08344
Domain	TRP_dom	TRPC1 TRPC5	1.66e-03	6	200	2	IPR013555
Domain	ABC_tran	ABCA1 ABCA13 ABCD3 ABCA5	1.72e-03	48	200	4	PF00005
Domain	ABC_TRANSPORTER_2	ABCA1 ABCA13 ABCD3 ABCA5	1.72e-03	48	200	4	PS50893
Domain	Spectrin	SPTB DST DMD	1.83e-03	23	200	3	PF00435
Domain	ACTININ_2	SPTB DST DMD	1.83e-03	23	200	3	PS00020
Domain	ACTININ_1	SPTB DST DMD	1.83e-03	23	200	3	PS00019
Domain	Actinin_actin-bd_CS	SPTB DST DMD	1.83e-03	23	200	3	IPR001589
Domain	ABC_TRANSPORTER_1	ABCA1 ABCA13 ABCD3 ABCA5	1.86e-03	49	200	4	PS00211
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	SETX ATRX MYO9B EXOC3 MCCC2 FAM111B POTEE ANAPC1 HELZ DIAPH3 DSCC1 PPP2R3C NCOA2 VPS50 FBRSL1 BCAR1 NOSIP USO1 ROCK1 CTNNB1 POTEI SLX4 SORL1 NIN	1.17e-13	588	204	24	38580884
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ATRX IQGAP2 RPN1 SIPA1L3 GATB PSMD2 CHD3 STOX1 PDE10A TEX10 RYR2 POTEE DST MIA2 SACS DIAPH3 DMD AGAP2 ESPN ANK2 POTEF CNTRL CCDC150 NARS2 TFRC GRPEL1 TRNT1 BRD2 DOK4 KIAA0825 TKT AVIL ANKRD30A POTEI DOP1A	9.47e-13	1442	204	35	35575683
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	IQGAP2 CKAP5 EXOC3 PSMD2 MCM6 MCCC2 EDC4 TEX10 AP1G1 ANAPC1 TUBGCP3 ABCD3 AFDN DHX35 COPB1 VPS50 MSH3 XPO1 THOC5 PPP2R5D USO1 ELMO2	2.79e-12	560	204	22	35241646
Pubmed	Defining the membrane proteome of NK cells.	CCDC134 AKAP8 RPN1 MYO9B CKAP5 PSMD2 EDC4 MELK DDX6 ITPR3 FAM120A MIA2 AP1G1 TUBGCP3 ABCD3 HELZ GPAT4 AGAP2 COPB1 CNTRL CEP290 VPS50 MSH3 XPO1 NMD3 TXLNA DCP1B USO1 LNPEP PSME3	1.22e-11	1168	204	30	19946888
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETX RPN1 MYO9B CKAP5 EXOC3 SRP54 PSMD2 MCM6 MCCC2 PHF8 TEX10 MELK DDX6 DST FAM120A AP1G1 TUBGCP3 ABCD3 CPSF1 AFDN COPB1 ISOC1 CASP8 MSH3 XPO1 DHX30 NMD3 TFRC GTF2H1 TKT PSME3 ZNF281	1.97e-11	1353	204	32	29467282
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	GOLM2 TBC1D5 SIPA1L3 EXOC3 PSMD2 PHF8 TEX10 ITPR3 ABCD3 CPSF1 HELZ DMD IFT57 CEP290 DUSP9 XPO1 BCAR1 POSTN GRPEL1 PPP2R5D BRD2 AKAP9 LNPEP SSU72 UBR3 ROCK1 MARVELD2 NIN	2.61e-11	1049	204	28	27880917
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	AKAP8 ATRX RPN1 GATB EXOC3 SRP54 MCCC2 ITPR3 FAM120A SACS TUBGCP3 ABCD3 DIAPH3 GPAT4 SHROOM3 ANK2 SHMT1 THOC5 DHX30 TFRC WDR19 GRPEL1 TXLNA IARS2 PPP2R5D BRD2 AKAP9 LNPEP MARVELD2 CTNNB1 SMCR8 NIN	2.15e-10	1487	204	32	33957083
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	AKAP8 RPN1 EXOC3 PSMD2 MCM6 CHD3 MCCC2 DDX6 AP1G1 CPSF1 COPB1 XPO1 DHX30 NMD3 NOSIP TXLNA USO1 RTRAF ROCK1 PSME3 CTNNB1	3.53e-10	653	204	21	33742100
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ATRX SPTB SIPA1L3 CKAP5 PSMD2 NCKAP5 ZNF214 RYR3 FN3K NAA25 DST FAM120A MIA2 SACS AFDN DHX35 SPARCL1 AGAP2 NCOA2 ANK2 COPB1 CEP290 MSH3 VPS54 DHX30 WDR19 BRD2 RTRAF SLX4	5.67e-10	1285	204	29	35914814
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ATRX RPN1 TRPC1 CKAP5 PSMD2 MCM6 MCCC2 EDC4 DDX6 FAM120A AP1G1 ANAPC1 ABCD3 CPSF1 AFDN FGD5 DNHD1 KIF27 COPB1 MSH3 XPO1 DHX30 NMD3 TFRC TXLNA IARS2 USO1 TKT RTRAF PSME3	1.41e-09	1425	204	30	30948266
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SETX AKAP8 TBC1D5 SIPA1L3 CKAP5 EDC4 MELK MAP3K3 DDX6 DST HELZ AFDN NR3C2 SHROOM3 POTEF BCAR1 NARS2 AKAP9 DCP1B USO1 ELMO2 OTUD7A DOP1A	1.75e-09	861	204	23	36931259
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	SETX AKAP8 ATRX CKAP5 SRP54 PSMD2 CHD3 EDC4 MELK DDX6 ANAPC1 TUBGCP3 CPSF1 DIAPH3 SHROOM3 KIF27 COPB1 BRD2 USO1	1.99e-09	582	204	19	20467437
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	AKAP8 MYO9B INSR CKAP5 EXOC3 PSMD2 MCM6 CHD3 EDC4 TEX10 DDX6 ITPR3 DST SACS ABCD3 CPSF1 AFDN COPB1 CEP290 XPO1 DHX30 TFRC BRD2 RTRAF CTNNB1	2.04e-09	1024	204	25	24711643
Pubmed	Human transcription factor protein interaction networks.	AKAP8 ATRX RPN1 PSMD2 CHD3 MCCC2 EDC4 PHF8 TEX10 FHAD1 DST FAM120A SPZ1 ABCD3 CPSF1 HELZ NCOA2 COPB1 FBRSL1 DHX30 TFRC NOSIP GRPEL1 BRD2 DCP1B PSME3 ZNF281 SLX4 SORL1	6.19e-09	1429	204	29	35140242
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	RPN1 CKAP5 PSMD2 MCM6 EDC4 COPB1 XPO1 TFRC IARS2 USO1 TKT	1.01e-08	179	204	11	36261009
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SETX ATRX TBC1D5 EXOC3 CHD3 FAM111B DST FAM120A AP1G1 TUBGCP3 ABCD3 HELZ AFDN UBE3B FBRSL1 GRPEL1 TXLNA ELMO2 SORL1	1.19e-08	650	204	19	38777146
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SETX AKAP8 IQGAP2 INSR LRRK2 MCCC2 RYR2 DST ABCD3 AFDN DCLRE1A TDRKH SHROOM3 COPB1 CNTRL IARS2 USO1 PSME3 MARVELD2 SMCR8	3.94e-08	777	204	20	35844135
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SETX AKAP8 IQGAP2 RPN1 SIPA1L3 SRP54 CHD3 TEX10 DDX6 FAM120A TUBGCP3 CPSF1 TRPM1 ANK2 COPB1 ISOC1 THOC5 TRUB2 NOSIP GRPEL1 TXLNA SPATS2L AKAP9 USO1 TKT RTRAF CTNNB1	4.02e-08	1371	204	27	36244648
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	RPN1 ABCA13 LRRK2 ABCD3 TRPM1 NCOA2 DNHD1 COPB1 XPO1 DOP1A SORL1	4.76e-08	208	204	11	33230847
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	AKAP8 IQGAP2 TBC1D5 SIPA1L3 CKAP5 EDC4 TEX10 ITIH1 DST FAM120A ANAPC1 AFDN AGAP2 NCOA2 SHROOM3 ANK2 NOSIP TXLNA PPP2R5D AKAP9 ROCK1 CTNNB1	6.48e-08	963	204	22	28671696
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	AKAP8 RPN1 SIPA1L3 CKAP5 PSMD2 EDC4 TEX10 DDX6 ITPR3 DST FAM120A ABCD3 CPSF1 ISOC1 XPO1 THOC5 DHX30 NOSIP TXLNA IARS2 GTF2H1 SPATS2L TKT RTRAF CTNNB1	1.11e-07	1257	204	25	36526897
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	SETX AKAP8 IQGAP2 MYO9B CKAP5 MCM6 BEND4 TEX10 FAM120A ANAPC1 NCOA2 KIF27 DUSP9 MSH3 IARS2 USO1 SSU72 ATF3 CTNNB1 SORL1	1.90e-07	857	204	20	25609649
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	RPN1 CKAP5 EXOC3 PSMD2 DDX6 DST ABCD3 AFDN DIAPH3 ANK2 COPB1 ISOC1 XPO1 TFRC PPP2R5D USO1 ROCK1 SMCR8	2.33e-07	708	204	18	39231216
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SETX AKAP8 ATRX SIPA1L3 CKAP5 SRP54 EDC4 TEX10 DDX6 POTEE DST AP1G1 ANAPC1 ABCD3 HELZ AFDN TDRKH SHROOM3 TBC1D30 ICE1 DHX30 GTF2H1 SPATS2L BRD2 LNPEP RTRAF ZNF281	2.33e-07	1497	204	27	31527615
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	RPN1 CKAP5 PSMD2 MCM6 EDC4 DDX6 AP1G1 TUBGCP3 ABCD3 COPB1 XPO1 DHX30 TFRC USO1 RTRAF PSME3 CTNNB1	2.66e-07	638	204	17	33239621
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	RPN1 CKAP5 SRP54 PSMD2 EDC4 DDX6 FAM120A ANAPC1 TRAPPC6B ABCD3 DMD COPB1 DHX30 TXLNA IARS2 PPP2R5D RTRAF PSME3 CTNNB1	3.55e-07	809	204	19	32129710
Pubmed	Functional proteomics mapping of a human signaling pathway.	ATRX CHD3 TEX10 RYR2 DST AP1G1 AFDN SPARCL1 DIAPH3 ZNF510 DHX30 IL36RN DCP1B LNPEP ROCK1 CTNNB1	4.91e-07	591	204	16	15231748
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	CACUL1 TBC1D5 LRRK2 ZNF214 PDE10A MIA2 GTF2A1L CNTRL CEP290 VPS50 ZNF510 MSH3 TIGD6 AXDND1 NPHP3 DCP1B PDZRN3	7.25e-07	686	204	17	29987050
Pubmed	Melanopsin signalling in mammalian iris and retina.	TRPC1 TRPC5 GNAT1 TRPV4	7.88e-07	13	204	4	22051675
Pubmed	The protein interaction landscape of the human CMGC kinase group.	AKAP8 SIPA1L3 INSR DDX6 ABCD3 CPSF1 FNTA DUSP9 ICE1 ZNF510 GTF2H1 AKAP9 ROCK1 PSME3 CTNNB1 ZNF281 SORL1	8.67e-07	695	204	17	23602568
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ATRX IQGAP2 EXOC3 MCM6 MELK MAP3K3 ABCD3 HELZ AFDN IFT57 UBE3B CEP290 VPS50 CCDC150 DHX30 WDR19 POSTN TXLNA GTF2H1 NPHP3 PPP2R5D DCP1B CTNNB1 SORL1	1.02e-06	1321	204	24	27173435
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IQGAP2 RPN1 SPTB SIPA1L3 CKAP5 PSMD2 CHD3 EDC4 DDX6 DST FAM120A AP1G1 SACS ABCD3 AFDN DMD AGAP2 ANK2 COPB1 XPO1 DHX30 USO1 TKT RTRAF CTNNB1	1.21e-06	1431	204	25	37142655
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	AKAP8 RPN1 EXOC3 SRP54 PSMD2 MCM6 CHD3 MCCC2 AK3 DDX6 CTPS2 FAM120A ANAPC1 ABCD3 FNTA IFT57 ISOC1 XPO1 DHX30 NMD3 NOSIP TKT RTRAF PSME3	1.23e-06	1335	204	24	29229926
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	AKAP8 SIPA1L3 INSR CKAP5 EXOC3 EDC4 DDX6 FAM120A ANAPC1 TUBGCP3 DHX35 GNAT1 PPP2R3C COPB1 XPO1 TRUB2 MAD2L1BP DHX30 TFRC PPP2R5D TKT SLX4	1.38e-06	1155	204	22	20360068
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	AKAP8 CKAP5 PSMD2 MCM6 FN3K ITPR3 FAM120A ABCD3 HELZ AFDN DIAPH3 DMD FNTA DUSP9 XPO1 TFRC LNPEP TKT PSME3 SORL1	1.39e-06	974	204	20	28675297
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	AKAP8 CKAP5 PSMD2 MCM6 DDX6 FAM120A COPB1 XPO1 TFRC GRPEL1 USO1 TKT PSME3 CTNNB1	1.53e-06	494	204	14	26831064
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	AKAP8 IQGAP2 RPN1 PSMD2 MCM6 MCCC2 DDX6 CTPS2 ANAPC1 ABCD3 CPSF1 GPAT4 COPB1 DUSP9 SHMT1 XPO1 TRUB2 DHX30 TFRC IARS2 RTRAF PSME3 CTNNB1	1.55e-06	1257	204	23	37317656
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	AKAP8 MELK FAM120A ANAPC1 HELZ DCLRE1A CEP290 VPS50 ICE1 TFRC IARS2 PPP2R5D DCP1B USO1 ROCK1 CTNNB1 PDZRN3	1.78e-06	733	204	17	34672954
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CKAP5 PSMD2 MCM6 EDC4 TEX10 ITPR3 DST FAM120A ANAPC1 CPSF1 HELZ AFDN COPB1 XPO1 DHX30 IARS2	1.80e-06	653	204	16	22586326
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	MYO9B SRP54 EDC4 DDX6 POTEE FAM120A AP1G1 TRUB2 NMD3 DCP1B PSME3 SORL1	1.86e-06	364	204	12	24778252
Pubmed	EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.	CKAP5 DST TUBGCP3 AKAP9 TKT PSME3	1.95e-06	63	204	6	29162697
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ATRX SRP54 MCM6 CHD3 PHF8 TEX10 MFAP4 ANAPC1 CPSF1 MSH3 XPO1 THOC5 TFRC NOSIP TRNT1 BRD2 SSU72 TKT PSME3 CTNNB1	2.55e-06	1014	204	20	32416067
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	RPN1 GATB SRP54 PSMD2 AK3 FAM111B ITPR3 POTEE DST FAM120A MIA2 ABCD3 CPSF1 DHX35 DIAPH3 GPAT4 TDRKH NARS2 TRUB2 DHX30 GRPEL1 IARS2 SPATS2L AKAP9 SMCR8	2.66e-06	1496	204	25	32877691
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	TRPC1 TRPC5 RYR2 RYR3 ITPR3	2.83e-06	38	204	5	30786075
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TBC1D5 SIPA1L3 CKAP5 MCCC2 PHF8 FAM120A AFDN RMC1 SHROOM3 CNTRL CEP290 CASP8 TXLNA IARS2 PPP2R5D ELMO2 PDZRN3 NIN	3.29e-06	853	204	18	28718761
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	AKAP8 RPN1 PSMD2 MCM6 EDC4 TEX10 ITPR3 NAA25 CTPS2 AP1G1 ABCD3 COPB1 XPO1 NMD3 TFRC PPP2R5D USO1 CTNNB1 ZNF281	3.34e-06	942	204	19	31073040
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	RPN1 SRP54 PSMD2 MCM6 MCCC2 EDC4 DDX6 ABCD3 CPSF1 COPB1 XPO1 DHX30 IARS2 TKT RTRAF	3.44e-06	607	204	15	39147351
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	CKAP5 SRP54 MCM6 DDX6 FAM120A CPSF1 DIAPH3 COPB1 XPO1 DHX30 USO1 TKT PSME3 CTNNB1	3.76e-06	534	204	14	35032548
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR2 RYR3 ITPR3	3.93e-06	6	204	3	25966694
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR2 RYR3 ITPR3	3.93e-06	6	204	3	20519450
Pubmed	DCP1 forms asymmetric trimers to assemble into active mRNA decapping complexes in metazoa.	EDC4 DDX6 DCP1B	3.93e-06	6	204	3	19966221
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR2 RYR3 ITPR3	3.93e-06	6	204	3	23463619
Pubmed	Shroom regulates epithelial cell shape via the apical positioning of an actomyosin network.	SHROOM3 ROCK1 CTNNB1	3.93e-06	6	204	3	16249236
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR2 RYR3 ITPR3	3.93e-06	6	204	3	16844763
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	ATRX EXOC3 MCM6 CHD3 EDC4 ANAPC1 COPB1 MSH3 XPO1 BRD2 TKT RTRAF	4.20e-06	394	204	12	27248496
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	AKAP8 IQGAP2 SRP54 MCM6 DDX6 CTPS2 AP1G1 ABCD3 COPB1 MSH3 NARS2 DHX30 NOSIP IARS2 USO1 SSU72	4.68e-06	704	204	16	29955894
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RPN1 MYO9B SIPA1L3 INSR PSMD2 MCM6 MCCC2 DDX6 ITPR3 FAM120A ABCD3 CPSF1 DHX35 COPB1 XPO1 THOC5 TRUB2 DHX30 AKAP9 USO1 CTNNB1 ZNF281	4.74e-06	1247	204	22	27684187
Pubmed	Stasimon/Tmem41b localizes to mitochondria-associated ER membranes and is essential for mouse embryonic development.	RPN1 PSMD2 ABCD3 GPAT4 COPB1 XPO1 TFRC	4.92e-06	113	204	7	30352685
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	AKAP8 CKAP5 SRP54 DDX6 FAM120A ANAPC1 HELZ DHX35 DCLRE1A DIAPH3 THOC5 NOSIP TXLNA SPATS2L TKT ZNF281	6.64e-06	724	204	16	36232890
Pubmed	ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia.	AKAP8 RPN1 PSMD2 MCM6 CTPS2 COPB1 TFRC IARS2	6.67e-06	166	204	8	35687106
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	AKAP8 RPN1 PSMD2 MCM6 MCCC2 TEX10 DDX6 ABCD3 XPO1 DHX30 NMD3 TFRC NOSIP GTF2H1 SPATS2L BRD2 TKT RTRAF CTNNB1	6.68e-06	989	204	19	36424410
Pubmed	Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.	RYR2 RYR3 ITPR3	6.84e-06	7	204	3	11860456
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	ATRX PHF8 TEX10 DCLRE1A MSH3 DHX30 BRD2 ZNF281 SLX4	7.19e-06	222	204	9	37071664
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	EDC4 DDX6 FAM120A HELZ XPO1 DHX30	7.92e-06	80	204	6	35803934
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	TBC1D5 DST AP1G1 TBC1D30 VPS50 MSH3 VPS54 TFRC PPP2R5D LNPEP	7.94e-06	285	204	10	34369648
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	CHD3 EDC4 ITPR3 FAM120A COPB1 CNTRL XPO1 NMD3 TXLNA NIN	7.94e-06	285	204	10	32838362
Pubmed	Comprehensive Proteomic Analysis of PGC7-Interacting Proteins.	AKAP8 EXOC3 MCM6 CHD3 TUBGCP3 PPP2R3C COPB1 CCDC150 TFRC PPP2R5D	8.44e-06	287	204	10	28712289
Pubmed	Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4.	AP1G1 COPB1 TFRC	1.09e-05	8	204	3	10444069
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR2 RYR3 ITPR3	1.09e-05	8	204	3	19033399
Pubmed	Mapping the expression of transient receptor potential channels across murine placental development.	TRPC1 TRPC5 TRPM1 TRPV4	1.11e-05	24	204	4	33884443
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATRX TBC1D5 CKAP5 SRP54 CHD3 EDC4 DST ABCD3 HELZ ANK2 COPB1 ICE1 DHX30 IARS2 TKT PSME3 SMCR8 ZNF281	1.13e-05	934	204	18	33916271
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	AKAP8 SRP54 GPAT4 KIF27 COPB1 POTEF TFRC TKT CTNNB1	1.13e-05	235	204	9	28378594
Pubmed	The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.	PSMD2 MCM6 ABCD3 CPSF1 COPB1 XPO1 NMD3 TXLNA TKT	1.21e-05	237	204	9	29564676
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ATRX PSMD2 MCM6 JADE1 EDC4 FAM186B DDX6 ANAPC1 CPSF1 HELZ DIAPH3 PPP2R3C VPS54 XPO1 TRUB2 MAD2L1BP DHX30 NOSIP BRD2 TRMT44 ELMO2 TKT	1.25e-05	1327	204	22	32694731
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	AKAP8 ATRX MCM6 TEX10 DDX6 ITPR3 ANAPC1 ABCD3 DHX35 DHX30 CTNNB1 SLX4	1.27e-05	440	204	12	34244565
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	CKAP5 MGAM COPB1 XPO1 DHX30 TFRC TKT CTNNB1	1.30e-05	182	204	8	31067453
Pubmed	International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels.	TRPC1 TRPC5 TRPM1 TRPV4	1.32e-05	25	204	4	16382100
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	CKAP5 TEX10 AP1G1 ABCD3 AFDN DMD KIF27 SHMT1 GRPEL1 ROCK1	1.39e-05	304	204	10	32235678
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TBC1D5 SIPA1L3 DDX6 DST ANAPC1 HELZ AFDN SHROOM3 PPP2R5D AKAP9 CTNNB1 NIN	1.45e-05	446	204	12	24255178
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	RPN1 CKAP5 SRP54 ABCD3 AFDN DIAPH3 ANK2 COPB1 XPO1 TFRC USO1 LNPEP	1.55e-05	449	204	12	31732153
Pubmed	Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse.	ABCD3 ABCA5 CTNNB1	1.63e-05	9	204	3	26122848
Pubmed	Switching of α-Catenin From Epithelial to Neuronal Type During Lens Epithelial Cell Differentiation.	SPTB ANK2 CTNNB1	1.63e-05	9	204	3	28692740
Pubmed	Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of trp channels.	TRPC1 TRPC5 ITPR3	1.63e-05	9	204	3	11290752
Pubmed	Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping.	EDC4 DDX6 DCP1B	1.63e-05	9	204	3	16364915
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	SETX PSMD2 TEX10 DCLRE1A SHLD2 ICE1 NOSIP GTF2H1 ATF3 PSME3 ZNF281 SLX4	1.69e-05	453	204	12	29656893
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	IQGAP2 PSMD2 MCCC2 ABCD3 CPSF1 DMD DHX30 TFRC IARS2 NPHP3	1.79e-05	313	204	10	38270169
Pubmed	An introduction to TRP channels.	TRPC1 TRPC5 TRPM1 TRPV4	1.81e-05	27	204	4	16460286
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	PSMD2 EDC4 DDX6 DST FAM120A HELZ DHX30 NOSIP SPATS2L RTRAF	1.89e-05	315	204	10	26777405
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	ATRX PSMD2 CHD3 DST GNAT1 DMD COPB1 POTEF DHX30 BRD2 ELMO2 TKT RTRAF	1.98e-05	538	204	13	28524877
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	PSMD2 RYR2 RYR3 FAM120A SHROOM3 COPB1 XPO1 SORL1	2.15e-05	195	204	8	17110338
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	TRPC5 MCCC2 RYR2 DST DMD GRPEL1 BRD2 ZNF281	2.31e-05	197	204	8	20811636
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SETX ATRX IQGAP2 SRP54 CHD3 JADE1 MAP3K3 AP1G1 RXFP2 NCOA2 SHLD2 CNTRL SHMT1 WDFY4 TRNT1 NPHP3 TLR4 ROCK1 SLX4	2.38e-05	1084	204	19	11544199
Pubmed	Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.	CKAP5 TUBGCP3 PPP2R3C CNTRL CEP290 AKAP9 NIN	2.62e-05	146	204	7	21399614
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYO9B CKAP5 ITPR3 ANAPC1 ICE1 XPO1 DHX30 ANKRD30A	2.76e-05	202	204	8	33005030
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	AKAP8 RPN1 CKAP5 CPSF1 HELZ AFDN COPB1 CTNNB1	2.86e-05	203	204	8	22083510
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	ATRX INSR MCCC2 TEX10 MAP3K3 DDX6 DST ANAPC1 DUSP9 FBRSL1 BCAR1 TXLNA GTF2H1 BRD2 AKAP9 PSME3 CTNNB1	2.95e-05	910	204	17	36736316
Pubmed	Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.	SIPA1L3 LRRK2 POTEE POTEF FREM3 TFRC POTEI	2.99e-05	149	204	7	22664934
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	RPN1 GOLM2 TBC1D5 CKAP5 PSMD2 TEX10 NAA25 MIA2 ANAPC1 ABCD3 AFDN GPAT4 COPB1 XPO1 TFRC PPP2R5D USO1 CTNNB1 ZNF281 SLX4	3.05e-05	1203	204	20	29180619
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	RPN1 MYO9B SPTB SIPA1L3 CKAP5 PSMD2 CHD3 ITIH1 MFAP4 ABCD3 HELZ SPATS2L TKT CTNNB1 NIN	3.11e-05	732	204	15	34732716
Pubmed	MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity.	RPN1 DST ABCD3 DUSP9 XPO1 SMCR8 ZNF281	3.12e-05	150	204	7	22678362
Interaction	C9orf78 interactions	IQGAP2 CKAP5 EXOC3 PSMD2 MCM6 MCCC2 EDC4 TEX10 AP1G1 ANAPC1 TUBGCP3 ABCD3 AFDN DHX35 COPB1 VPS50 MSH3 XPO1 BCAR1 THOC5 PPP2R5D USO1 ELMO2	7.20e-08	620	202	23	int:C9orf78
Interaction	YWHAH interactions	SETX AKAP8 TBC1D5 SIPA1L3 LRRK2 CKAP5 PSMD2 EDC4 MELK MAP3K3 DDX6 DST AFDN DCLRE1A NR3C2 NCOA2 SHROOM3 POTEF CNTRL CEP290 ISOC1 XPO1 BCAR1 GRPEL1 IARS2 AKAP9 DCP1B CDCA7 OTUD7A DOP1A NIN	1.86e-07	1102	202	31	int:YWHAH
Interaction	GSK3B interactions	GOLM2 SIPA1L3 LRRK2 SRP54 PSMD2 MCM6 CHD3 EDC4 DST FAM120A AGAP2 DUSP9 XPO1 BCAR1 TFRC IARS2 PPP2R5D DCP1B USO1 ATF3 PSME3 CTNNB1 ZNF281 SLX4 NIN	2.13e-06	868	202	25	int:GSK3B
Interaction	KCNA3 interactions	RPN1 ABCA13 LRRK2 CKAP5 EXOC3 PSMD2 DDX6 DST ABCD3 AFDN TRPM1 DIAPH3 NCOA2 DNHD1 ANK2 COPB1 ISOC1 XPO1 TFRC PPP2R5D USO1 ROCK1 SMCR8 DOP1A SORL1	2.26e-06	871	202	25	int:KCNA3
Interaction	ENKUR interactions	TRPC1 TRPC5 LRRK2 CTNNB1	4.55e-06	12	202	4	int:ENKUR
Interaction	TRIM33 interactions	RPN1 CKAP5 PSMD2 MCM6 EDC4 ANAPC1 COPB1 XPO1 TFRC IARS2 USO1 TKT PSME3 CTNNB1 SLX4 NIN	1.42e-05	453	202	16	int:TRIM33
Interaction	RHOF interactions	RPN1 MYO9B TBC1D5 SIPA1L3 EXOC3 TEX10 MELK POTEE NAA25 DIAPH3 GPAT4 MSH3 XPO1 DHX30 NMD3 TFRC LNPEP ROCK1 MARVELD2 CTNNB1	1.52e-05	673	202	20	int:RHOF
Interaction	ABCA5 interactions	ABCA13 ABCA5 CTNNB1	3.37e-05	7	202	3	int:ABCA5
Interaction	EGLN3 interactions	SETX RPN1 SIPA1L3 CKAP5 SRP54 PSMD2 MCCC2 PHF8 ANAPC1 TUBGCP3 ABCD3 HELZ NR3C2 DIAPH3 NCOA2 COPB1 DUSP9 SHMT1 ISOC1 ICE1 XPO1 NOSIP TXLNA PSME3 CTNNB1 ZNF281 PDZRN3 SLX4 NIN	4.02e-05	1296	202	29	int:EGLN3
Interaction	EFNB1 interactions	SETX CKAP5 FAM120A SACS TUBGCP3 AFDN SHMT1 XPO1 DIRAS3 USO1 TNFSF8	5.56e-05	255	202	11	int:EFNB1
Cytoband	Ensembl 112 genes in cytogenetic band chr2q21	MCM6 NCKAP5 POTEE POTEF CCDC74A POTEI	6.24e-05	151	204	6	chr2q21
Cytoband	2q21.1	POTEE POTEF CCDC74A POTEI	1.33e-04	58	204	4	2q21.1
GeneFamily	Transient receptor potential cation channels	TRPC1 TRPC5 TRPM1 TRPV4	4.43e-05	28	129	4	249
GeneFamily	Ankyrin repeat domain containing	ANKRD53 POTEE AGAP2 ESPN ANK2 POTEF ANKRD30A TRPV4 POTEI	6.04e-05	242	129	9	403
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEE POTEF POTEI	9.63e-05	13	129	3	685
GeneFamily	ATP binding cassette subfamily A	ABCA1 ABCA13 ABCA5	1.22e-04	14	129	3	805
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	1.51e-04	3	129	2	287
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	TRPC5 ITPR3 SACS SPZ1 VPS54 AKAP9	1.91e-03	181	129	6	694
GeneFamily	UPF1 like RNA helicases	SETX HELZ	2.66e-03	11	129	2	1169
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	AKAP8 CKAP5 SRP54 JADE1 PDE10A CTPS2 TRPM1 DMD NCOA2 TDRKH ANK2 ADAMTS2 IFT57 FAT3 CEP290 CAPN6 ANO1 TFRC WDR19 POSTN AKAP9 DCP1B KIAA0825 UBR3 ROCK1 MARVELD2 DOP1A	6.67e-07	983	201	27	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500	SETX IQGAP2 GOLM2 INSR RYR2 DDX6 FAT3 MSH3 LNPEP	2.86e-05	165	201	9	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000	SETX ATRX GOLM2 CKAP5 MCM6 BEND4 CCDC163 DSCC1 PPP2R3C TDRKH SHROOM3 FAT3 SHMT1 CITED1 MSH3 DHX30 TFRC TRNT1 LNPEP UBR3	5.35e-05	779	201	20	gudmap_developingKidney_e15.5_Cap mesenchyme_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	ABCA1 SETX ATRX IQGAP2 GOLM2 INSR RYR2 DDX6 FAT3 MSH3 AKAP9 LNPEP	7.69e-05	330	201	12	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	ABCA1 SETX IQGAP2 GOLM2 INSR RYR2 MFAP4 ANAPC1 NCOA2 FAT3 TFRC AKAP9 LNPEP	8.21e-05	385	201	13	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	SETX ATRX IQGAP2 INSR FHAD1 FAM120A CNTRL CEP290 AKAP9 ROCK1	2.99e-08	199	204	10	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	ATRX INSR JADE1 DST FAM120A SHROOM3 CEP290 AKAP9 ROCK1 ZNF281	2.99e-08	199	204	10	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ATRX CKAP5 FAM120A LCORL MSH3 AKAP9 MARVELD2 SMCR8 ZNF281	2.80e-07	193	204	9	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	SETX ATRX IQGAP2 INSR FAM120A CEP290 AKAP9 ROCK1 SORL1	3.63e-07	199	204	9	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	SETX INSR SRP54 FHAD1 FAM120A CNTRL CEP290 AKAP9 ROCK1	3.63e-07	199	204	9	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A5 RYR2 MFAP4 DST SPARCL1 ADAMTS2 FAT3 ANO1 PDZRN3	3.63e-07	199	204	9	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	NS-critical-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCKAP5 DST ESPN ANK2 FAT3 POSTN FSBP PDZRN3	1.11e-06	168	204	8	6a233045638cb83dab64789b996b7598c325001e
ToppCell	Bac-SEP-Myeloid-cDC1\|Bac-SEP / Disease, Lineage and Cell Type	EVC NCKAP5 DST FGD5 DMD WDFY4 SPATS2L CCDC74A	1.39e-06	173	204	8	f88269327441858ddb8c49b9dd619b76fd53b1da
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX CKAP5 SRP54 RYR2 MFAP4 NR3C2 DMD LNPEP	1.58e-06	176	204	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX ATRX SRP54 DDX6 MIA2 CNTRL LNPEP ATF3	2.20e-06	184	204	8	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	RYR2 RYR3 DMD SHROOM3 FAT3 ANO1 ROCK1 PDZRN3	2.58e-06	188	204	8	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATRX JADE1 DST AFDN ADAMTS2 AKAP9 CTNNB1 NIN	2.79e-06	190	204	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MELK FAM111B DIAPH3 DSCC1 FAT3 GLYATL2 CCDC150 SHMT1	2.79e-06	190	204	8	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RYR2 DST SPARCL1 ANK2 ADAMTS2 FAT3 ANO1 PDZRN3	2.90e-06	191	204	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RYR2 DST SPARCL1 ANK2 ADAMTS2 FAT3 ANO1 PDZRN3	3.02e-06	192	204	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 PDE10A RYR2 MFAP4 ANK2 ADAMTS2 FAT3 PDZRN3	3.02e-06	192	204	8	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MCM6 MELK FAM111B DIAPH3 GLYATL2 ANO1 CCDC150 CDCA7	3.26e-06	194	204	8	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MCM6 MELK FAM111B DIAPH3 DSCC1 GLYATL2 CCDC150 CDCA7	3.38e-06	195	204	8	b65463a804fed2d9a3be9e528ca8b9c98469bc86
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MCM6 MELK FAM111B DIAPH3 DSCC1 GLYATL2 CCDC150 CDCA7	3.38e-06	195	204	8	56d8734d020b3da08a5aa9e67999706a9e023a99
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A5 RYR2 MFAP4 DST SPARCL1 ADAMTS2 FAT3 PDZRN3	3.51e-06	196	204	8	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A5 RYR2 MFAP4 DST SPARCL1 ADAMTS2 FAT3 PDZRN3	3.51e-06	196	204	8	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RYR2 MFAP4 DST SPARCL1 ANK2 ADAMTS2 FAT3 PDZRN3	3.51e-06	196	204	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Healthy-T/NK_proliferative\|World / disease group, cell group and cell class	MCM6 MELK FAM111B DIAPH3 DSCC1 CCDC150 SHMT1 CDCA7	3.65e-06	197	204	8	e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A5 STOX1 RYR2 RYR3 MFAP4 ANK2 ADAMTS2 CAPN6	3.79e-06	198	204	8	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RYR2 MFAP4 DST SPARCL1 ANK2 ADAMTS2 FAT3 PDZRN3	3.79e-06	198	204	8	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	CACUL1 MCM6 MELK TUBGCP3 NCOA2 SHMT1 XPO1 CDCA7	3.93e-06	199	204	8	fd1d1b95e01719e3d0a17d9d1f29717a47209d32
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	CACUL1 MCM6 MELK TUBGCP3 NCOA2 SHMT1 XPO1 CDCA7	3.93e-06	199	204	8	91882af9dc7265c9b419f4415cbcf656087a2ab3
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SETX ATRX DDX6 HELZ CASP8 XPO1 AKAP9 ROCK1	4.08e-06	200	204	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RYR2 DST SPARCL1 ANK2 ADAMTS2 FAT3 ANO1 PDZRN3	4.08e-06	200	204	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA1 COL6A5 RYR2 MFAP4 DST ANK2 AKAP9 PDZRN3	4.08e-06	200	204	8	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	BEND4 DST SACS AFDN AGAP2 AKAP9 CDCA7 PDZRN3	4.08e-06	200	204	8	c6bbd33bca86ac7a76a7ba704b3e141237d04549
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A5 RYR2 MFAP4 SPARCL1 ANK2 ADAMTS2 FAT3 PDZRN3	4.08e-06	200	204	8	8c62f05c6042f24287a73fbdf80ff4a56f7ff403
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MFAP4 DST SPARCL1 DMD ANO1 POSTN SPATS2L PDZRN3	4.08e-06	200	204	8	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MFAP4 DST SPARCL1 DMD ANO1 POSTN SPATS2L PDZRN3	4.08e-06	200	204	8	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MFAP4 DST SPARCL1 DMD ANO1 POSTN SPATS2L PDZRN3	4.08e-06	200	204	8	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RYR2 DST SPARCL1 ANK2 ADAMTS2 FAT3 ANO1 PDZRN3	4.08e-06	200	204	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	(24)_B_cell_cycling\|World / shred on Cell_type and subtype	ATRX MELK FAM111B DIAPH3 DMD DSCC1 CCDC150 CDCA7	4.39e-06	202	204	8	a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe
ToppCell	390C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FAM111B MFAP4 DST ESPN COPB1 DIRAS3 SORL1	6.59e-06	152	204	7	4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781
ToppCell	390C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FAM111B MFAP4 DST ESPN COPB1 DIRAS3 SORL1	6.59e-06	152	204	7	ebce79e106bf1d84241f8dd3496ff1771f9666be
ToppCell	NS-control-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCKAP5 ANK2 FAT3 WDFY4 POSTN ANKRD30A PDZRN3	1.17e-05	166	204	7	6d9fb239f69ba519844f593c00d515e1aac4ff50
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	AKAP8 TBC1D5 FAM186B AFDN UBE3B WDR19 IARS2	1.17e-05	166	204	7	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	URO-Myeloid-cDC1\|URO / Disease, Lineage and Cell Type	MORC1 NCKAP5 ZNF214 DST DMD WDFY4 CCDC74A	1.53e-05	173	204	7	57f4e9f39ef6e02dca76f3dd0b39a0871917ed5a
ToppCell	NS-moderate-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPTB NCKAP5 DST ANK2 POSTN ELMO2 OTUD7A	1.65e-05	175	204	7	a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCell	NS-moderate-d_07-13-Epithelial-Ionocyte\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCKAP5 DST ESPN ANK2 FAT3 POSTN PDZRN3	1.78e-05	177	204	7	99500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCell	NS-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCKAP5 DST ESPN ANK2 FAT3 POSTN PDZRN3	1.91e-05	179	204	7	65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c
ToppCell	NS-moderate-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCKAP5 DST ANK2 FAT3 POSTN ANKRD30A PDZRN3	1.98e-05	180	204	7	8af8b4af2dc72223ac71fc027e0d4280c5dd81f8
ToppCell	3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast\|bone_marrow / Manually curated celltypes from each tissue	SPTB PSMD2 CTPS2 DSCC1 MAD2L1BP MMRN1 FSBP	2.28e-05	184	204	7	030d5ef5e44e4d973862128fe01f7e8ef0092a06
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ITPR3 NR3C2 SHROOM3 RASGRF1 LRRC36	2.53e-05	187	204	7	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	RYR2 DST SPARCL1 ADAMTS2 FAT3 ANO1 PDZRN3	2.53e-05	187	204	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	3'_v3-Lung-Myeloid_Dendritic-Cycling_Dendritic\|Lung / Manually curated celltypes from each tissue	BEND4 STOX1 MELK FAM111B AFDN DIAPH3 RASGRF1	2.62e-05	188	204	7	0e8ac42c439f30a05e015210e1d5c2dcb9d9d471
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 DST PDILT SHROOM3 ANK2 DUSP9 SHMT1	2.62e-05	188	204	7	14e120b20e76baa07b6510a94f0c2dcdfdd52357
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 ARHGEF38 EVC ITPR3 DST DIAPH3 LNPEP	2.71e-05	189	204	7	aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCell	moderate-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NCKAP5 JADE1 DST ANK2 FAT3 POSTN PDZRN3	2.71e-05	189	204	7	6011b747e27d61d222380a7bffdd921a68e9b657
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 DST PDILT SHROOM3 ANK2 DUSP9 SHMT1	2.71e-05	189	204	7	443359d90fafae0c1de6bdcce9e8c95df6ea4de8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 ARHGEF38 EVC ITPR3 DST DIAPH3 LNPEP	2.71e-05	189	204	7	8977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 PDE10A RYR2 MFAP4 ANK2 FAT3 PDZRN3	2.71e-05	189	204	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	RYR2 DST SPARCL1 ANK2 ADAMTS2 FAT3 PDZRN3	2.80e-05	190	204	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STOX1 KL TUBGCP3 KCNN4 DMD TRMT44 TRPV4	2.80e-05	190	204	7	3cf464664d6aa22b212e60b70885953887e92483
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	NCKAP5 RYR2 FN3K DST DMD ANK2 PDZRN3	2.80e-05	190	204	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 PDE10A RYR2 MFAP4 ANK2 FAT3 PDZRN3	2.89e-05	191	204	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	APCDD1 COL6A5 RYR2 MFAP4 DST SPARCL1 ANK2	2.89e-05	191	204	7	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RYR2 SPARCL1 DMD ANK2 ANO1 POSTN PDZRN3	2.89e-05	191	204	7	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IQGAP2 SIPA1L3 AFDN NR3C2 MGAM SHROOM3 TRPV4	2.89e-05	191	204	7	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 RYR2 MFAP4 DMD FAT3 ANO1 PDZRN3	2.89e-05	191	204	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	APCDD1 COL6A5 RYR2 MFAP4 DST SPARCL1 ANK2	2.89e-05	191	204	7	1726add3f392a061536b7aff72ba84303f4a0b1f
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 PDE10A RYR2 MFAP4 ANK2 ADAMTS2 PDZRN3	2.99e-05	192	204	7	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ITPR3 NR3C2 SHROOM3 RASGRF1 LRRC36	2.99e-05	192	204	7	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 PDE10A RYR2 MFAP4 ANK2 FAT3 PDZRN3	2.99e-05	192	204	7	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	RYR2 MFAP4 DST FAT3 ANO1 POSTN PDZRN3	2.99e-05	192	204	7	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	Control-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	ABCA1 INSR LRRK2 NCOA2 TBC1D30 AOAH NIN	3.09e-05	193	204	7	3479c01aaae7afd7e02d00e0cb21951c0106a0fd
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	INSR NCKAP5 RYR2 DMD ANK2 DCP1B PDZRN3	3.09e-05	193	204	7	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	COL6A5 NCKAP5 RYR2 DST SPARCL1 FAT3 ANO1	3.09e-05	193	204	7	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Pro-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MCM6 MELK FAM111B DIAPH3 DSCC1 CCDC150 CDCA7	3.20e-05	194	204	7	3590ff471f74a361ee5bf02a58e3104cd3bf7d00
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 LRRK2 ARHGEF38 EVC ITPR3 AFDN DIAPH3	3.20e-05	194	204	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 RYR2 MFAP4 DMD ANK2 FAT3 PDZRN3	3.20e-05	194	204	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MELK RYR2 RYR3 DIAPH3 CCDC150 POSTN	3.29e-05	132	204	6	02491930097b75aaeedab9e8200711b0dc610944
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	ABCA1 IQGAP2 MYO9B AOAH WDFY4 TFRC TLR4	3.30e-05	195	204	7	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	INSR NCKAP5 RYR2 DST DMD ANK2 PDZRN3	3.30e-05	195	204	7	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MCM6 MELK FAM111B DIAPH3 DSCC1 GLYATL2 CDCA7	3.30e-05	195	204	7	cec7df321f372d05c94f97d6bb18891a5cc3dec3
ToppCell	Control-Myeloid-ncMonocyte\|Control / Disease state, Lineage and Cell class	ABCA1 MYO9B INSR LRRK2 TBC1D30 AOAH NIN	3.30e-05	195	204	7	fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	COL6A5 RYR2 DST SPARCL1 ADAMTS2 FAT3 PDZRN3	3.30e-05	195	204	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	(4)_B_Hypermutation\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ATRX MCM6 MELK FAM111B DIAPH3 DSCC1 CDCA7	3.30e-05	195	204	7	54d2acaff6be6b5604591bdbd7d769ac3e74f223
ToppCell	Control-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	ABCA1 MYO9B INSR LRRK2 TBC1D30 AOAH NIN	3.30e-05	195	204	7	b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST AFDN DMD POSTN TRPV4 CTNNB1 PDZRN3	3.41e-05	196	204	7	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST AFDN DMD POSTN TRPV4 CTNNB1 PDZRN3	3.41e-05	196	204	7	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	Healthy-T/NK_proliferative\|Healthy / disease group, cell group and cell class	MCM6 MELK FAM111B DIAPH3 DSCC1 CCDC150 CDCA7	3.41e-05	196	204	7	91e44aabb2e85dcc77ddae6f7e000118d45d1de6
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABCA1 COL6A5 RYR2 MFAP4 DST ANK2 PDZRN3	3.52e-05	197	204	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABCA1 IQGAP2 MYO9B ADAMTS2 AOAH WDFY4 SORL1	3.52e-05	197	204	7	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	(3)_Chondrocytes-(30)_Chondro\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	GOLM2 SPARCL1 SLC35E3 CAPN6 TFRC SPATS2L TRPV4	3.52e-05	197	204	7	a07ab2564ca7d577fd47f444dd7b0c25556e9fc4
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RYR2 MFAP4 DST SPARCL1 ANK2 ADAMTS2 PDZRN3	3.52e-05	197	204	7	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RYR2 SACS SPARCL1 DMD FAT3 ANO1 PDZRN3	3.52e-05	197	204	7	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	Healthy_donor-T/NK_proliferative\|Healthy_donor / disease group, cell group and cell class (v2)	MCM6 MELK FAM111B DIAPH3 DSCC1 SHMT1 CDCA7	3.52e-05	197	204	7	b6bbf87e5823fa66b4cad6a7be4f777356887b59
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Basal_1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	NCKAP5 DST NR3C2 ANK2 FAT3 POSTN ANKRD30A	3.64e-05	198	204	7	f632342e1e8911dd82b5df171776a84c7dc3f931
ToppCell	(0)_NK_cells-(0)_NK_Dividing\|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	ATRX MCM6 MELK FAM111B DIAPH3 DSCC1 CDCA7	3.64e-05	198	204	7	d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb
ToppCell	(1)_T_cell_dividing\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ATRX MCM6 MELK FAM111B DIAPH3 DSCC1 CDCA7	3.64e-05	198	204	7	dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RYR2 MFAP4 DST SPARCL1 ADAMTS2 FAT3 PDZRN3	3.64e-05	198	204	7	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A5 RYR2 MFAP4 DST SPARCL1 ADAMTS2 FAT3	3.64e-05	198	204	7	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	(0)_NK_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ATRX MCM6 MELK FAM111B DIAPH3 DSCC1 CDCA7	3.64e-05	198	204	7	5ebb4965b723302152b42bfaf48bb77a57dd02c5
ToppCell	(4)_B_cells-(4)_B_Hypermutation\|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ATRX MCM6 MELK FAM111B DIAPH3 DSCC1 CDCA7	3.64e-05	198	204	7	8be724a49b4c911d68c3e82fb75e96722d0eaa03
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A5 RYR2 MFAP4 DST ADAMTS2 FAT3 PDZRN3	3.64e-05	198	204	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
Disease	Colorectal Carcinoma	ABCA1 CACUL1 ABCA13 KL SACS PDILT ABCD3 NR3C2 DMD MYOT ANK2 CAPN6 CASP8 TFRC POSTN AKAP9 ABCA5 TLR4 CTNNB1 SORL1	7.03e-08	702	199	20	C0009402
Disease	Malignant neoplasm of breast	AKAP8 ARHGEF38 NAA25 MIA2 FGD5 DMD AGAP2 NCOA2 ANK2 SHMT1 CASP8 BCAR1 THOC5 TFRC AKAP9 ANKRD30A CLUL1 CTNNB1 ZNF281 DOP1A SORL1	1.33e-05	1074	199	21	C0006142
Disease	Colorectal Neoplasms	ABCA1 CACUL1 ABCA13 ABCD3 CASP8 TFRC POSTN ABCA5 TLR4 CTNNB1	2.03e-05	277	199	10	C0009404
Disease	chronic kidney disease	RPN1 SIPA1L3 PSMD2 COL6A5 PDILT DHX35 DIAPH3 SHROOM3 PDZRN3	3.35e-05	235	199	9	EFO_0003884
Disease	PROSTATE CANCER, HEREDITARY, 1	MYO9B CHD3 FBRSL1 CASP8 CDCA7	5.36e-05	60	199	5	C4722327
Disease	Renal dysplasia and retinal aplasia (disorder)	CEP290 WDR19 NPHP3	6.36e-05	12	199	3	C0403553
Disease	Antihypertensive use measurement	MYO9B INSR PDE10A PDILT FGD5 RMC1 UBE3B KIAA0825 TKT	8.46e-05	265	199	9	EFO_0009927
Disease	Prostate cancer, familial	MYO9B CHD3 FBRSL1 CASP8 CDCA7	1.05e-04	69	199	5	C2931456
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	1.35e-04	3	199	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	1.35e-04	3	199	2	DOID:8545 (implicated_via_orthology)
Disease	hypertension	MYO9B INSR COL6A5 RXFP2 NR3C2 FGD5 LCORL FBRSL1 BCAR1	2.54e-04	307	199	9	EFO_0000537
Disease	Duchenne and Becker Muscular Dystrophy	DMD POSTN	4.47e-04	5	199	2	C3542021
Disease	monocyte:lymphocyte ratio	RPN1 PSMD2	4.47e-04	5	199	2	EFO_0007956
Disease	Becker Muscular Dystrophy	DMD POSTN	4.47e-04	5	199	2	C0917713
Disease	stroke	CHD3 NAA25 ANK2 ADAMTS2 WDFY4 NIN	4.50e-04	144	199	6	EFO_0000712
Disease	Fever, response to sulfasalazine	PDE10A OTUD7A	6.67e-04	6	199	2	EFO_0008324, HP_0001945
Disease	pappalysin-1 measurement	RPN1 PSMD2	6.67e-04	6	199	2	EFO_0802845
Disease	Muscular Dystrophy, Duchenne	DMD POSTN	6.67e-04	6	199	2	C0013264
Disease	prostate cancer (is_marker_for)	PHF8 AGAP2 NCOA2 TFRC ATF3 CTNNB1	6.86e-04	156	199	6	DOID:10283 (is_marker_for)
Disease	alcohol consumption measurement	PSMD2 NCKAP5 BEND4 JADE1 AP1G1 SDHAF2 NR3C2 RMC1 NCOA2 MGAM LCORL UBE3B FBRSL1 NOSIP WDR19 MMRN1 AKAP9 TKT SORL1	7.87e-04	1242	199	19	EFO_0007878
Disease	Senior-Loken syndrome (is_implicated_in)	CEP290 WDR19	9.29e-04	7	199	2	DOID:0050576 (is_implicated_in)
Disease	Renal dysplasia and retinal aplasia	CEP290 WDR19	9.29e-04	7	199	2	cv:C0403553
Disease	1,5 anhydroglucitol measurement	MCM6 NCKAP5 MGAM	9.70e-04	29	199	3	EFO_0008009
Disease	blood urea nitrogen measurement	INSR MCM6 NAA25 PDILT DMD SHROOM3 LCORL DUSP9 NMD3 SORL1	1.05e-03	452	199	10	EFO_0004741
Disease	Ventricular Dysfunction, Left	NR3C2 TLR4 CTNNB1	1.07e-03	30	199	3	C0242698
Disease	Alzheimer disease, survival time	NCKAP5 NARS2	1.23e-03	8	199	2	EFO_0000714, MONDO_0004975
Disease	proteoglycan 3 measurement	RPN1 PSMD2	1.23e-03	8	199	2	EFO_0802970
Disease	HEPATOCELLULAR CARCINOMA	CASP8 CTNNB1	1.58e-03	9	199	2	114550
Disease	Adult Hepatocellular Carcinoma	CASP8 CTNNB1	1.58e-03	9	199	2	C0279607
Disease	Hepatocellular carcinoma	CASP8 CTNNB1	1.58e-03	9	199	2	cv:C2239176
Disease	post operative nausea and vomiting	FAT3 SPATS2L	1.58e-03	9	199	2	EFO_0004888
Disease	Neoplasm Invasiveness	DMD BCAR1 TKT TLR4 CTNNB1 SORL1	1.61e-03	184	199	6	C0027626
Disease	Meckel-Gruber syndrome	CEP290 NPHP3	1.97e-03	10	199	2	cv:C0265215
Disease	Muscle Weakness	DMD MYOT	1.97e-03	10	199	2	C0151786
Disease	dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement	RPN1 PSMD2	1.97e-03	10	199	2	EFO_0801544
Disease	Cryptorchidism	ATRX RXFP2	1.97e-03	10	199	2	C0010417
Disease	age at onset, multiple sclerosis	NCKAP5 AXDND1	1.97e-03	10	199	2	EFO_0004847, MONDO_0005301
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	RYR2 ANK2	1.97e-03	10	199	2	C1631597
Disease	temporomandibular joint disorder	RXFP2 DMD	1.97e-03	10	199	2	EFO_0005279
Disease	sex interaction measurement, Crohn's disease	LRRK2 XPO1 TNFSF8	1.98e-03	37	199	3	EFO_0000384, EFO_0008343
Disease	gastric adenocarcinoma (is_implicated_in)	ABCA13 XPO1	2.39e-03	11	199	2	DOID:3717 (is_implicated_in)
Disease	ciliopathy (implicated_via_orthology)	IFT57 CEP290 WDR19	2.48e-03	40	199	3	DOID:0060340 (implicated_via_orthology)
Disease	Night blindness, congenital stationary, type 1	TRPM1 GNAT1	2.86e-03	12	199	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	TRPM1 GNAT1	2.86e-03	12	199	2	C3495587
Disease	chronic kidney disease (implicated_via_orthology)	INSR SHROOM3	2.86e-03	12	199	2	DOID:784 (implicated_via_orthology)
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	TRPM1 GNAT1	2.86e-03	12	199	2	C1864877
Disease	nicotine dependence (implicated_via_orthology)	TRPC1 TRPC5	2.86e-03	12	199	2	DOID:0050742 (implicated_via_orthology)
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	TRPM1 GNAT1	2.86e-03	12	199	2	C1850362
Disease	X-Linked Csnb	TRPM1 GNAT1	2.86e-03	12	199	2	C3711543
Disease	Charcot-Marie-Tooth Disease	SETX TRPV4	2.86e-03	12	199	2	C0007959
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	TRPM1 GNAT1	2.86e-03	12	199	2	C1848172
Disease	pulse pressure measurement	INSR CKAP5 FAM186B ITIH1 RXFP2 KCNN4 DCLRE1A FGD5 SHROOM3 ANK2 LCORL FAT3 CNTRL FBRSL1 ANO1 BCAR1 CDCA7 UBR3 NIN	2.88e-03	1392	199	19	EFO_0005763
Disease	hemoglobin A1 measurement	CACUL1 MYO9B SPTB FN3K NAA25 KL MGAM LCORL DUSP9 CASP8	2.93e-03	520	199	10	EFO_0007629
Disease	neurodegenerative disease (implicated_via_orthology)	TRPC1 TRPC5 LRRK2 PSMD2 UBR3	3.09e-03	145	199	5	DOID:1289 (implicated_via_orthology)
Disease	Memory impairment	KL LNPEP TRPV4	3.27e-03	44	199	3	C0233794
Disease	Cone-rod synaptic disorder, congenital nonprogressive	TRPM1 GNAT1	3.36e-03	13	199	2	C4041558
Disease	pulmonary emphysema (implicated_via_orthology)	KL TLR4	3.36e-03	13	199	2	DOID:9675 (implicated_via_orthology)
Disease	Nephronophthisis	WDR19 NPHP3	3.36e-03	13	199	2	C0687120
Disease	Gastric Adenocarcinoma	INSR BRD2 CTNNB1	3.48e-03	45	199	3	C0278701
Disease	severe acute respiratory syndrome, COVID-19	RPN1 PSMD2 PDILT TRPM1 DMD NCOA2 POTEF WDFY4 AXDND1	3.49e-03	447	199	9	EFO_0000694, MONDO_0100096
Disease	Neurodevelopmental Disorders	ANK2 DHX30 PPP2R5D CTNNB1	3.67e-03	93	199	4	C1535926
Disease	autism spectrum disorder (implicated_via_orthology)	TRPC1 TRPC5 ITPR3 NR3C2 CTNNB1	3.77e-03	152	199	5	DOID:0060041 (implicated_via_orthology)
Disease	Diabetic Neuralgia	INSR TLR4	3.90e-03	14	199	2	C0751074
Disease	Diabetic Neuropathies	INSR TLR4	3.90e-03	14	199	2	C0011882
Disease	Asymmetric Diabetic Proximal Motor Neuropathy	INSR TLR4	3.90e-03	14	199	2	C0271674
Disease	Symmetric Diabetic Proximal Motor Neuropathy	INSR TLR4	3.90e-03	14	199	2	C0271673
Disease	Diabetic Mononeuropathy	INSR TLR4	3.90e-03	14	199	2	C0271678
Disease	Diabetic Autonomic Neuropathy	INSR TLR4	3.90e-03	14	199	2	C0271686
Disease	Diabetic Amyotrophy	INSR TLR4	3.90e-03	14	199	2	C0271685
Disease	Diabetic Polyneuropathies	INSR TLR4	3.90e-03	14	199	2	C0271680
Disease	Diabetic Asymmetric Polyneuropathy	INSR TLR4	3.90e-03	14	199	2	C0393835
Disease	diabetic neuropathy (implicated_via_orthology)	INSR TLR4	3.90e-03	14	199	2	DOID:9743 (implicated_via_orthology)
Disease	Cardiomyopathy, Dilated	NR3C2 DMD CTNNB1	4.18e-03	48	199	3	C0007193
Disease	Paroxysmal atrial fibrillation	MYOT FBRSL1 XPO1 SPATS2L SORL1	4.21e-03	156	199	5	C0235480
Disease	familial atrial fibrillation	MYOT FBRSL1 XPO1 SPATS2L SORL1	4.21e-03	156	199	5	C3468561
Disease	Persistent atrial fibrillation	MYOT FBRSL1 XPO1 SPATS2L SORL1	4.21e-03	156	199	5	C2585653
Disease	hepatocellular carcinoma (implicated_via_orthology)	IQGAP2 INSR XPO1	4.43e-03	49	199	3	DOID:684 (implicated_via_orthology)
Disease	cortical surface area measurement	IQGAP2 APCDD1 MYO9B TBC1D5 NCKAP5 STOX1 NR3C2 DIAPH3 NCOA2 SHROOM3 COPB1 LCORL FAT3 XPO1 NOSIP KIAA0825 TREH PDZRN3	4.54e-03	1345	199	18	EFO_0010736
Disease	Atrial Fibrillation	MYOT FBRSL1 XPO1 SPATS2L SORL1	4.69e-03	160	199	5	C0004238
Disease	Cardiomyopathy, Familial Idiopathic	NR3C2 DMD CTNNB1	4.69e-03	50	199	3	C1449563
Disease	Romano-Ward Syndrome	ANK2 AKAP9	5.10e-03	16	199	2	C0035828
Disease	reaction time measurement	AKAP8 IQGAP2 LRRK2 GATB NCKAP5 NAA25 KIF27 ADAMTS2 FBRSL1 MSH3 SPATS2L	5.29e-03	658	199	11	EFO_0008393
Disease	Night blindness, congenital stationary	TRPM1 GNAT1	5.76e-03	17	199	2	C0339535
Disease	Peripheral Nervous System Diseases	ABCA1 MYOT ATF3	5.82e-03	54	199	3	C4721453
Disease	hepatocellular carcinoma (biomarker_via_orthology)	ABCA1 INSR CASP8 TFRC	6.23e-03	108	199	4	DOID:684 (biomarker_via_orthology)
Disease	HbA1c measurement	MYO9B SPTB FN3K NAA25 KL RXFP2 LCORL DUSP9 CASP8 FREM3 TFRC	6.36e-03	675	199	11	EFO_0004541
Disease	Meckel syndrome type 1	CEP290 NPHP3	6.45e-03	18	199	2	C3714506
Disease	Ciliopathies	EVC CEP290 WDR19 NPHP3	6.65e-03	110	199	4	C4277690

Protein segments in the cluster

Peptide	Gene	Start	Entry
MENAENHKIKAYTQL	ABCA5	1041	Q8WWZ7
QDVLAHLVQMAFKYL	AFDN	716	P55196
QIYRHQQKIKEMQLD	FBRSL1	601	Q9HCM7
KFMNSHLQKPYEINL	DDX6	286	P26196
IHYKQQIDGLQNEMS	AKAP9	661	Q99996
MHTLLNKVTEEYNKL	AKAP9	1256	Q99996
IIDQKQKSTIMLYHI	AVIL	241	O75366
IHYLQENLKSMEEIQ	CNTRL	916	Q7Z7A1
MTEKQQELLFHYLQL	CATSPER1	731	Q8NEC5
MNHLNVLAKALYDNV	BCAR1	1	P56945
VLNNRHIVKMLEKYL	AKAP8	526	O43823
AHQMELQLSYNFTLK	ADAM20	181	O43506
LSHCIQSLKKIYMQE	ARHGEF38	211	Q9NXL2
SVLKEKHRNMLQYQL	ABCA1	2166	O95477
TVLDYLKMVLQHHNQ	BEND4	356	Q6ZU67
QIMEYIRKLSKNHQN	ANKRD30A	256	Q9BXX3
LETVQQHLYMLAKSL	ABCA13	3031	Q86UQ4
TIHGLIYNALKLFME	PPP2R5D	461	Q14738
QYKKEMLVDGQTHLV	AGAP2	441	Q99490
HLNRKLSMEDQLYII	DOP1A	206	Q5JWR5
REKLVQQYGMLLEHS	GATB	381	O75879
SLETKYRHLQMQATK	FAM186B	256	Q8IYM0
LNLLLEYQKHMETFD	DMD	1671	P11532
QLQYKRLEMNSNPLH	DNHD1	4621	Q96M86
TLSKLHENMEKLYQS	DIAPH3	966	Q9NSV4
QRLQEALGMHESKYL	DHX30	686	Q7L2E3
ENKDLHYKLIMNQTS	CCDC74A	81	Q96AQ1
MQKELKLLQYQLSQH	CCDC163	76	A0A0D9SF12
HVQKYLLTLMNIVNE	ADAMTS2	286	O95450
SEQMYSDLIKKITNH	CACUL1	176	Q86Y37
SIVRAHKMQQLKEQY	PDZRN3	701	Q9UPQ7
QEYLQQLESHMKSRK	EDC4	1146	Q6P2E9
VIQLLHMKSNKYLTV	ITPR3	121	Q14573
QLYHVLETANKIFMV	MELK	71	Q14680
LEYILHQKKEIARQM	NOSIP	71	Q9Y314
EFLNVQEYNHLLKVM	MORC1	416	Q86VD1
QYLNLDKDHNGMLSK	PPP2R3C	281	Q969Q6
LHLVYEELKLNTLMG	ANAPC1	766	Q9H1A4
MAAQENHIDVVKYLL	ANK2	136	Q01484
IKLTYNHKGSAMQDL	AP1G1	796	O43747
KLYSNVMQTLKHLNS	AOAH	391	P28039
KSQLTLMEHNYLIEY	ANKRD53	286	Q8N9V6
PLELQYIEMKQQHKD	MSH3	231	P20585
HVICQLLSDYKEKQM	POTEF	351	A5A3E0
MLKHAVVNLINYQDD	CTNNB1	131	P35222
KVFEMSQDKNLYHNL	MCM6	336	Q14566
IQKFLSLYGDQIDMH	ISOC1	51	Q96CN7
FYQLTKLLDSMHDLV	NR3C2	921	P08235
QFTCELLKHIMYQRQ	MAD2L1BP	71	Q15013
NLDVIAHGYQSTMLK	KIAA0825	236	Q8IV33
HIMQLNEEYLKEQLF	KIAA0825	1146	Q8IV33
ISKMHMILYDLQQNL	KCNN4	371	O15554
YKQMKALVNQLHERV	MCCC2	46	Q9HCC0
QLTYEEVLKRNHMQY	ITIH1	161	P19827
VKQMKIIHQDGYSLE	GNAT1	46	P11488
KMLLSEVTNLIYHKN	LIPM	366	Q5VYY2
HLKNLYEGLVMTEVQ	GRPEL1	136	Q9HAV7
KYQQNMSHLEEKLLL	MMRN1	836	Q13201
QHTEKMHEYLTLLQD	DST	3396	Q03001
LDVTYHKNEMLQFKI	MGAM	1936	O43451
YLHQLTLQKMVTQFK	LCORL	381	Q8N3X6
AADIYMQTKNKLRHV	ESPN	466	B1AK53
MTRLALHELKNLTQY	AK3	71	Q9UIJ7
IDTQLYIHQMISVKN	CPSF1	1206	Q10570
LEQSVDHMKYQKIQL	KIF27	841	Q86VH2
HTYDDLLHKNQQLTM	LRRC36	641	Q1X8D7
AIDSLLEHIMIYAKN	PDE10A	266	Q9Y233
LEHIMIYAKNLVNAD	PDE10A	271	Q9Y233
DLNDYLQHILKSTNM	COPB1	861	P53618
LSSEKAYVEMLQHLN	FGD5	901	Q6ZNL6
FLITQLKMLNTNYHL	MT-ATP8	21	P03928
TVAYLMQKLHLSLND	DUSP9	301	Q99956
MQKLHLSLNDAYDLV	DUSP9	306	Q99956
NLLMYQNSLHEKIGD	LRRK2	376	Q5S007
LLMLKTYLSEDVFQH	LNPEP	556	Q9UIQ6
MGNQVEKLTHLSYKE	LRATD2	1	Q96KN1
LDVLNKKYSLLDHMQ	TUBGCP3	546	Q96CW5
MYHINETRGLLKKIN	ANO1	181	Q5XXA6
QYLMHEVAKQLDLNP	FAM120A	216	Q9NZB2
VHLKELGLYNLMNIT	INSR	126	P06213
SLEAKLNLLHSYMNV	OTUD7A	426	Q8TE49
TEDLEYLMHAKQQLV	HELZ	386	P42694
MKDSALKVLYLHNNQ	IL36RN	11	Q9UBH0
HVICQLLSDYKEKQM	POTEE	351	Q6S8J3
LMKNLTQYEQLKAHQ	DCP1B	126	Q8IZD4
QLRLIYNTHMADEKL	CKAP5	1591	Q14008
IEYHCMVNFIKENLL	ATRX	1756	P46100
EIMEYKEQIKQHAQT	FHAD1	921	B1AJZ9
IDLNVLKAQTYHLDM	IFT57	206	Q9NWB7
SELKIQKISMDHNYI	ICE1	1976	Q9Y2F5
DYEMKLLNHVTQLVD	DSCC1	201	Q9BVC3
TSLQNDHLRKMNKYL	CCDC150	581	Q8NCX0
MLALDNMLYLAKVHQ	ELMO2	371	Q96JJ3
EEQQKLYSKMIVGNH	GPAT4	436	Q86UL3
EYQQMLHNLREKLKN	CEP290	326	O15078
KELQLEIFHLVMYRN	CHD3	566	Q12873
YLQLNTEHICDSIMK	CYP2A7	46	P20853
LTMLNIYEAFIKHNK	DHX35	546	Q9H5Z1
LLHILKKEQTIYNMI	AXDND1	251	Q5T1B0
KKEQTIYNMIFHELI	AXDND1	256	Q5T1B0
KKQYQDHMINLTIHL	COL6A5	826	A8TX70
DFITYDNQLLMKNHI	COL6A5	2031	A8TX70
IKNNNLSKDHYMLIV	FAT3	1941	Q8TDW7
MHELQLIRVEKQYLH	APCDD1	206	Q8J025
QIEELKNEKQHLIYM	ATF3	131	P18847
QIYEILKIYQLMDHS	CASP8	291	Q14790
LSHIKQRIQEYDKVM	MARVELD2	536	Q8N4S9
MQNYINEALKAHILD	KL	891	Q9UEF7
HLKTLQGERMENYKL	EVC	811	P57679
LLADQKVHMLYLDTT	DCLRE1A	826	Q6PJP8
NLLKNYQTLNEAIMH	FAM111B	386	Q6SJ93
EIFKNLLNMYHQALS	EXOC3	306	O60645
HKVIMSLQQKDLRTY	CAPN6	396	Q9Y6Q1
VNVQELFHMLLNYKK	DIRAS3	186	O95661
VAKLGMNLTKHDVYN	EFCAB3	76	Q8N7B9
HISMVIQKIYLKSDQ	SACS	1331	Q9NZJ4
EHMNTLLGNILKIIY	RYR2	3271	Q92736
MEKNVRLLNKGTEHY	DOK4	241	Q8TEW6
LDLHYMNNELSILLK	MAP3K3	81	Q99759
KEHLQHMTEKQLNLY	SDHAF2	91	Q9NX18
HMTEKQLNLYDRLIN	SDHAF2	96	Q9NX18
LYQENEMKLHRKLTV	MIA2	996	Q96PC5
LKQAMTLEFKVYQHQ	SHMT1	316	P34896
YNTENKDLISELHIM	PDILT	261	Q8N807
LEMTVQEYQLTHFQK	FREM3	711	P0C091
ISYQMADIHHLKEQL	GOLM2	116	Q6P4E1
LQIQRHDDYLVMLKA	RTRAF	141	Q9Y224
IVTHYKNMIREQDLQ	USO1	651	O60763
KYHIIVQLGNMSKDS	SORL1	2001	Q92673
LKVKMSNVYQIQLSH	TRMT44	226	Q8IYL2
LQYMEKHHILQIFQQ	TEX55	501	Q96M34
TMKVLYQSHLLKQIL	TIGD6	321	Q17RP2
LKYQGEHCLLKEMQQ	TRNT1	366	Q96Q11
KLKHGQFTLRDMYEQ	SRP54	321	P61011
MAELNTHVNVKEKIY	SPATS2L	1	Q9NUQ6
MDSNKYIEHLLTQLE	NCKAP5	26	O14513
YKEHLNSMVVERQQL	NIN	901	Q8N4C6
ALVNLAVLYSQMKKH	NPHP3	1221	Q7Z494
LAAMLRQLAQYHAKD	PSMD2	741	Q13200
EHMLKNNFLIISYTE	NARS2	311	Q96I59
LQKQNTMNYLAHEEL	IQGAP2	351	Q13576
QYTLEMIKLVPHNES	FNTA	261	P49354
SKLGEQMADLHLYNQ	FN3K	101	Q9H479
QMADLHLYNQKLREK	FN3K	106	Q9H479
NMHLLTLKQKYELRV	MFAP4	116	P55083
VHYTFNKVLMLQEPL	RPN1	426	P04843
GKVYQLEVMLKQLHT	SIPA1L3	1716	O60292
QMENDNYKLIELIHG	SETX	1511	Q7Z333
KKVMLTVEQAQDQHY	SHLD2	621	Q86V20
YQHFVKMKSTLLIEQ	SHROOM3	1921	Q8TF72
LMYLHKNQFESLKQL	RXFP2	341	Q8WXD0
HVICQLLSDYKEKQM	POTEI	351	P0CG38
LAQQHNKMEIYADII	WDR19	986	Q8NEZ3
DQYMLHLLQDLANKI	IARS2	756	Q9NSE4
DLITAMKLHDSYQLN	JADE1	51	Q6IE81
HEALMQKYLHLLQIV	RASGRF1	136	Q13972
LLYTLIEKTMQNVKH	TFRC	501	P02786
MVLKLKEIFQYTHQT	SLX4	1591	Q8IY92
VVQYLAELLKLHYMQ	SMCR8	901	Q8TEV9
QVLKDLNHGKYERTM	ABCD3	396	P28288
TNQLQYLHKVVMKAL	BRD2	76	P25440
LNDIHQQYKILDVML	CCDC134	56	Q9H6E4
VHAYLKSLKQEFEMQ	CDCA7	356	Q9BWT1
LLASMHLQKLNSQYQ	CITED1	91	Q99966
QYGQILQMTRKHLED	CLUL1	356	Q15846
QEELMNKSVYSILHV	NCOA2	151	Q15596
NQYVTLHDMILKNIE	PSME3	226	P61289
AAHRNNYEILTMLLK	TRPC1	166	P48995
KEIMSQHNIYVDALL	VPS50	806	Q96JG6
LAINHKLNLMYIDSI	CTPS2	326	Q9NRF8
QMVPNDIQSELKHLY	GTF2H1	451	P32780
LVSHIEEMLQTAYNK	GTF2H1	521	P32780
DQTVQEHLIEKYMLL	XPO1	646	O14980
MQTKHVYQNLSQFLL	TNFSF8	181	P32971
KLNVAHVLFMQENKY	TTC30B	461	Q8N4P2
LQLDKLVNEMTQHYE	TDRKH	331	Q9Y2W6
SSHLEQNSQLLIYKM	LINC00643	36	Q86TS7
MESYHKPDQQKLQAL	TKT	1	P29401
IKTLVQHNLFYMLHQ	RMC1	506	Q96DM3
VTDIQLHILKNRMYG	GTF2A1L	291	Q9UNN4
QNQKAMFEHLSYLLE	RYR3	2106	Q15413
VDNLIKHTVLMQKYE	STOX1	371	Q6ZVD7
LKNILMQLYEANSEH	SPARCL1	531	Q14515
LFLLLHNEMVSGVYK	TRAPPC6B	6	Q86SZ2
LLTQMSAGKQYLEHA	TRAPPC6B	101	Q86SZ2
YDPQILQMLKEEHQI	FSBP	231	O95073
MLQNFLDLVKTYGHV	TREH	196	O43280
MLERKFLEYQQLTHK	WDFY4	46	Q6ZS81
MGFIQKYLLQRHEKI	ZNF281	296	Q9Y2X9
KLNIKDLLSQMHHYN	TEX10	56	Q9NXF1
NLAMIISISYFKQLH	TAAR2	61	Q9P1P5
HQMLYLRQKDANELK	TBC1D30	151	Q9Y2I9
SSVELLMKYHQGINA	SPTB	1936	P11277
TIYKLEEQLHNEMQL	ROCK1	431	Q13464
QSYKHDEQIAMKLLT	TRPM1	686	Q7Z4N2
DYGLNESMHLITKQL	UBE3B	371	Q7Z3V4
TLLYKILMDHQNLSE	UBR3	931	Q6ZT12
KLNVAHVLFMQENKY	TTC30A	461	Q86WT1
STVEEYNKLNMGIKH	ZNF510	321	Q9Y2H8
LHSLNIEMQLKAYEI	PHF8	371	Q9UPP1
QVKKLSHDTYSLQLM	SPZ1	306	Q9BXG8
IMLAAHTNNYEIIKL	TRPC5	146	Q9UL62
ENEQLLYKQGMHELL	TBC1D5	196	Q92609
SHQKALVMYSNLDLK	TRUB2	171	O95900
QNLLYEVMHLQKEIT	THOC5	131	Q13769
ASEALMKYHILNTLQ	POSTN	296	Q15063
LQVLDYSLNHIMTSK	TLR4	546	O00206
YSLNHIMTSKKQELQ	TLR4	551	O00206
ILVYNSKIENRHEML	TRPV4	436	Q9HBA0
KQHELQVNSMQLLYY	SLC35E3	176	Q7Z769
KDKELYTQNGILHML	SSU72	71	Q9NP77
LSMEKEQKLIVQHSY	ZNF214	176	Q9UL59
MKQQETHLKQQLALY	TXLNA	376	P40222
VYNKLKLMATVHQTQ	VPS54	286	Q9P1Q0
MLVLHNSQKLQILYK	GLYATL2	1	Q8WU03
EKLYRDLHNQMIKSI	MYO9B	736	Q13459
TRLLGLYHTMDKNQK	NAA25	421	Q14CX7
LYHTMDKNQKLSVVR	NAA25	426	Q14CX7
LLHNGNQRLTYEEKM	MYOT	171	Q9UBF9
YLEQLILKYGMHQNT	NMD3	171	Q96D46
ILKYGMHQNTLRIKE	NMD3	176	Q96D46